Latest Approved Drug Stories

Lee Rannals for redOrbit.com - Your Universe Online The U.S. Food and Drug Administration (FDA) has issued announcements of its approval of new drugs before the start of the new year. The FDA has approved a new drug to help treat high cholesterol known as Juxtapid, which helps take care of a rare genetic form of high cholesterol. The condition, which affects about 3,000 Americans, causes super-high cholesterol levels and heart attacks at an early age. The drug injections will cost...

LONDON, October 22, 2012 /PRNewswire/ -- Tracking Drugs@FDA and Orange Book Patent Data Provides Unrivaled Analysis of FDA Market Intelligence EvaluatePharma [http://www.evaluatepharma.com ], the premier source for life science sector analysis and consensus forecasts, today launched a new service enhancement, Tracking Drugs@FDA, which gives clients access to the entire universe of approved FDA drugs and the related FDA document library as well as FDA Orange Book patent...

Connie K. Ho for RedOrbit.com Every year, 50 million people throughout the world contract amebiasis through contaminated food or water. With this shocking statistic, it is considered the third leading cause of illness and the fourth leading cause of death due to protozoan infection on a global basis. A collaborative project by researchers from the University of California, San Francisco (UCSF), the University of California, San Diego (UCSD), and Wake Forest Medical School recently...

Pharmaceutical drugs approved by the Food and Drug Administration (FDA) but later re-called from the market—such as the antidiabetic drug Avandia and pain-reliever Vioxx—were the impetus for an Institute of Medicine committee report released yesterday, recommending that the FDA take proactive steps to continue monitoring drugs' safety after initial approval and throughout their time on the market. One of the key recommendations made by the report, Ethical and Scientific Issues in...

Confirmatory trials show significantly prolonged survival in patients; drug granted regular approval SILVER SPRING, Md., Jan. 31, 2012 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today granted Gleevec (imatinib) regular approval for use in adult patients following surgical removal of CD117-positive gastrointestinal stromal tumors (GIST). Today's action also highlights an increase in overall patient survival when the drug is taken for 36 months rather than the...

SILVER SPRING, Md., Dec. 27, 2011 /PRNewswire-USNewswire/ -- Consumers are warned not to use the ShoulderFlex Massager--a home massager that has caused a death and a near-strangulation when a necklace and clothing became caught in the device. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) Other alerts or safety information issued by the Food and Drug Administration in November includes the following products: TNF blocker drugs that may be associated with a possible cancer...

SILVER SPRING, Md., Dec. 1, 2011 /PRNewswire-USNewswire/ -- The Food and Drug Administration (FDA) has recently issued safety alerts about a number of products, including a potentially contaminated nasal spraycontact lenses that may cause eye injuriesan unapproved drug sold as a testosterone booster(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) These and other alerts were prompted by reports FDA received from health care professionals and the public through the agency's MedWatch...

Lawyers at Blumenthal Nordrehaug & Bhowmik File Brief Opposing Metropolitan Water District's motion to dismiss a highly contested lawsuit involving the use of a drug that is not approved by the FDA in public drinking water. San Diego, California (PRWEB) November 28, 2011 On November 23, 2011, the attorneys at Blumenthal Nordrehaug & Bhowmik filed a brief opposing the Metropolitan Water District’s motion to dismiss a lawsuit alleging that the Metropolitan Water District...

Websites touted products as cure or treatment for diseases SILVER SPRING, Md., Sept. 14, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration announced today that two Minnesota companies have agreed to halt distribution of amino-acid products marketed to treat a number of diseases, until requirements of the Federal Food, Drug, and Cosmetic Act are met. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) West Duluth Distribution Co., a corporation doing business as...

SILVER SPRING, Md., July 25, 2011 /PRNewswire-USNewswire/ --The Food and Drug Administration (FDA) has recently issued safety alerts about a number of products, including: (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) a wart and mole remover that can cause severe skin burnsan unapproved drug sold as a "sexual enhancer"a diabetes medicine that carries an increased risk of bladder canceranti-seizure medicines that can lower a child's IQ when taken by the mother while...